• 1. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 2. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 3. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 4. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 5. An alternative biorefinery approach to address microalgal seasonality: blending with spent coffee grounds
  Andre Prates Pereira,Tao Dong,Eric P. Knoshaug,Nick Nagle,Ryan Spiller,Bonnie Panczak,Christopher J. Chuck,Philip T. Pienkos Sustainable Energy Fuels, 2020,4, 3400-3408

Research Brief on 2'-Fluoro-2-methyl1,1'-biphenyl-4-amine (CAS: 946713-98-0): Recent Advances and Applications

2'-Fluoro-2-methyl1,1'-biphenyl-4-amine (CAS: 946713-98-0) is a fluorinated biphenyl derivative that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its unique structural properties and potential therapeutic applications. Recent studies have explored its role as a key intermediate in the synthesis of bioactive molecules, particularly in the development of kinase inhibitors and other small-molecule therapeutics. This research brief aims to summarize the latest findings related to this compound, highlighting its synthetic utility, biological activities, and emerging applications in drug discovery.

One of the most notable advancements in the study of 2'-Fluoro-2-methyl1,1'-biphenyl-4-amine is its incorporation into the design of novel kinase inhibitors. Kinases play a critical role in cellular signaling pathways, and their dysregulation is implicated in various diseases, including cancer and inflammatory disorders. Researchers have successfully utilized this compound as a building block to develop selective inhibitors targeting specific kinases, such as JAK2 and EGFR. The fluorine substitution at the 2'-position enhances the metabolic stability and binding affinity of these inhibitors, making them promising candidates for further preclinical evaluation.

In addition to its role in kinase inhibitor development, 2'-Fluoro-2-methyl1,1'-biphenyl-4-amine has been investigated for its potential applications in positron emission tomography (PET) imaging. The incorporation of fluorine-18 isotopes into the molecule allows for the creation of radiolabeled probes that can be used to study drug distribution and target engagement in vivo. Recent studies have demonstrated the feasibility of synthesizing [18F]-labeled derivatives of this compound, opening new avenues for non-invasive imaging in oncology and neurology research.

The synthetic routes to 2'-Fluoro-2-methyl1,1'-biphenyl-4-amine have also been optimized in recent years, with a focus on improving yield and scalability. Palladium-catalyzed cross-coupling reactions, such as Suzuki-Miyaura and Buchwald-Hartwig couplings, have been successfully employed to construct the biphenyl core with high efficiency. These advancements are critical for ensuring a reliable supply of the compound for both research and potential industrial-scale production.

Despite these promising developments, challenges remain in the full characterization of the pharmacological and toxicological profiles of 2'-Fluoro-2-methyl1,1'-biphenyl-4-amine and its derivatives. Ongoing studies are addressing these gaps, with particular emphasis on understanding its metabolic fate and potential off-target effects. Future research directions may include the exploration of its utility in other therapeutic areas, such as infectious diseases and neurodegenerative disorders, as well as the development of more sophisticated delivery systems to enhance its bioavailability.

In conclusion, 2'-Fluoro-2-methyl1,1'-biphenyl-4-amine (CAS: 946713-98-0) represents a versatile and valuable scaffold in medicinal chemistry, with demonstrated applications in kinase inhibitor design and PET imaging. Continued research into its properties and derivatives is expected to yield further insights and innovations in drug discovery and development. This compound exemplifies the intersection of chemical synthesis and biological application, underscoring the importance of interdisciplinary collaboration in advancing pharmaceutical science.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)